Showing results (121-130 of 308) with videos related to

Sort By:
Pageof 31
Pharmaceutical Medicine|November 3, 2020
Risk Minimisation Evaluation with Process Indicators and Behavioural or Health Outcomes in Europe: Systematic ReviewEsther Artime, Nawab Qizilbash, Rafael Herruzo, et al.
Pharmaceutical Medicine|July 29, 2022
The Use of Artificial Intelligence in Pharmacovigilance: A Systematic Review of the LiteratureMaribel Salas, Jan Petracek, Priyanka Yalamanchili, et al.
Pharmaceutical Medicine|December 20, 2013
Analysis of US Food and Drug Administration Warning Letters: False Promotional Claims Relating to Prescription and Over-the-Counter MedicationsMaribel Salas, Michelle Martin, Maria Pisu, et al.
Pharmaceutical Medicine|August 22, 2017
Risk Perceptions in Diabetic Patients Who Have Experienced Adverse Events: Implications for Patient Involvement in Regulatory DecisionsMikkel Lindskov Sachs, Sofia Kälvemark Sporrong, Morten Colding-Jørgensen, et al.
Pharmaceutical Medicine|August 23, 2017
Defining biological subsets in systemic lupus erythematosus: progress toward personalized therapyNailú Angélica Sinicato, Mariana Postal, Simone Appenzeller, et al.
Pharmaceutical Medicine|December 5, 2015
Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the USChi Y Bahk, Melanie Goshgarian, Krystal Donahue, et al.
Pharmaceutical Medicine|June 9, 2016
A Method for Retrieval of Adverse Event Terms in Clinical Trial Databases Using Standardised MedDRA QueriesChristopher D Breder
Pharmaceutical Medicine|September 7, 2021
Why Does the Precautionary Principle Suffice for Blood Regulation?Alexandra Seifner, Anthony W Fox
Pharmaceutical Medicine|May 22, 2020
Reliability and Validity of the M-MALMAS Instrument to Assess Medication Adherence in Malay-Speaking Patients with Type 2 DiabetesPauline Siew Mei Lai, Renukha Sellappans, Siew Siang Chua
Pharmaceutical Medicine|July 21, 2025
Utilization of Evidence Blueprint Initiative to Transform Capability Development in AstraZeneca SpainJesús Medina, Joaquín Sánchez-Covisa, Javier Nuevo, et al.
Pageof 31